ShanX Medtech Secures €15 Million to Accelerate Rapid Antibiotic Treatment
Eindhoven, Thursday 15 January 2026
Backed by Invest-NL and the EU, ShanX Medtech raised €15 million. Their technology cuts antibiotic diagnosis time from days to the same day, significantly bolstering the fight against resistance.
Strategic Consortium Drives Lab-to-Market Transition
This substantial financial commitment is orchestrated by a diverse consortium led by the Borski Fund, with participation from NextGen Ventures, the Brabant Development Agency (BOM), CbusineZ, and a strategic angel investor [1]. Invest-NL’s contribution of €1 million [1] constitutes approximately 6.667% of the core €15 million seed capital, a figure that underscores the state-backed fund’s role in de-risking deep-tech ventures. The financing is designed to accelerate the clinical validation of ShanX Medtech’s system, facilitating the critical transition from laboratory development to commercial market introduction [1].
Revolutionising Diagnostics to Combat Resistance
At the core of this investment lies a breakthrough in point-of-care diagnostics. While current standard practices require two to three days to identify the appropriate antibiotic, ShanX Medtech’s system delivers results on the same day [1]. This acceleration is pivotal for patient outcomes; as noted by Mats Wassink, Investment Manager at Invest-NL, accessible diagnostics enable general practitioners to choose the correct treatment immediately, thereby curbing unnecessary antibiotic use [1]. This precision is a vital tool in the global battle against Antimicrobial Resistance (AMR), directly mitigating one of the world’s most pressing health threats [1].
A Week of Momentum for Dutch Innovation
The ShanX announcement sits alongside a flurry of activity in the Dutch startup ecosystem observed this week. Yesterday, 14 January 2026, Eindhoven-based Touchwaves successfully raised €1.5 million to advance its wearable technology for pilots [2]. This development highlights the region’s continued strength in high-tech hardware applications. In parallel developments on 14 January, Amsterdam’s Voltico B.V. secured a convertible loan of €300,000 from Innovatiefonds Noord-Holland [2]. Furthermore, the broader European landscape saw a massive injection of capital, with Ghent-based Aikido Security raising over €51 million ($60 million) [2], signalling robust investor confidence across the continent.